Cardiovascular disease is the leading cause of death worldwide, largely because we have no drugs to treat the two most acute manifestations of this disease — heart attack and stroke. 

Infensa Bioscience is developing game-changing drugs to reduce the mortality and morbidity associated with these devastating disorders.